POS0875 DEFINING THE THRESHOLD OF NORMALITY IN MUSCULOSKELETAL ULTRASOUND; AN OMERACT ULTRASOUND STUDY
Ilfita Sahbudin(Queen Elizabeth Hospital Birmingham), Maria Antonietta D’Agostino(Agostino Gemelli University Polyclinic), C. Pineda(Instituto Nacional de Rehabilitación), P. Mandl(Medical University of Vienna), Mads Ammitzbøll‐Danielsen(Copenhagen University Hospital), Georgios Filippou(ASST Fatebenefratelli Sacco), Mihaela Maruseac(Cliniques Universitaires Saint-Luc), Irene Azzolin(University of Turin), Carina Borst(Medical University of Vienna), Florentin Ananu Vreju(University of Medicine and Pharmacy of Craiova), Garifallia Sakellariou(University of Pavia), G. Bruyn(Tergooi), H. B. Hammer(University of Oslo), Marcin Milchert(Pomeranian Medical University), Daniela Fodor(Iuliu Hațieganu University of Medicine and Pharmacy), M. Kortekaas(Leiden University Medical Center), Lene Terslev(Frederiksberg Hospital), Hélène Gouze(Inserm), Jacek Fliciński(Pomeranian Medical University), Andrew Filer(Birmingham City University), C. Sifuentes-Cantú(Hospital Universitario Fundación Jiménez Díaz), Cristina Reátegui-Sokolova(Instituto Nacional de Rehabilitación), Ilaria Tinazzi(Ospedale Sacro Cuore Don Calabria), E. M. Hauge(Aarhus University Hospital), G. M. C. La Paglia(Hospital Universitario Fundación Jiménez Díaz), Annamaria Iagnocco(University of Turin), S. Ohrndorf(Charité - Universitätsmedizin Berlin), E. Naredo(Hospital Universitario Fundación Jiménez Díaz), M. I. Gutiérrez(Instituto Nacional de Rehabilitación), Ruth Wittoek(Ghent University Hospital), Kei Ikeda(Dokkyo Medical University), Helen Keen(The University of Western Australia), G. Léon(Instituto Nacional de Rehabilitación), T. Serban, Coziana Ciurtin(University College Hospital), Rositsa Karalilova(Medical University Plovdiv), Jeanette Trickey(University of Birmingham), M. A. Mortada(Zagazig University), M. Nyhuus Bendix Rasch(University of Tübingen), Maria Stoenoiu(Cliniques Universitaires Saint-Luc), Takaaki Suzuki, P. Carron(Ghent University Hospital)
Cited by 2
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
|Journal of Infection|2020|1.2k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668